Asst. Prof.

BANU İSKENDER İZGİ


Tıp Fakültesi

Temel Tıp Bilimleri

Tıbbi Biyoloji

Education Information

2008 - 2012

2008 - 2012

Doctorate

The University of Manchester, Yaşam Bilimleri Fakültesi- Faculty of Life Sciences, Kök Hücre Araştırmaları- Stem Cell Research, England

2007 - 2008

2007 - 2008

Postgraduate

University of Newcastle Upon Tyne, Tıbbi Bilimler Fakültesi- Faculty of Medical Sciences, Tıbbi ve Moleküler Bilimler- Medical and Molecular Biosciences, England

2000 - 2004

2000 - 2004

Undergraduate

Eskisehir Osmangazi University, Fen Edebiyat Fakültesi, Biyoloji Bölümü, Turkey

Research Areas

Medicine, Health Sciences, Fundamental Medical Sciences, Medical Biology, Life Sciences, Biochemistry, Biomolecules, Molecular Biochemistry, Molecular Biology and Genetics, Moleculer Biology of Cancer, Natural Sciences

Academic Titles / Tasks

2021 - Continues

2021 - Continues

Assistant Professor

Kocaeli University, Tıp Fakültesi, Temel Tıp Bilimleri

2014 - 2021

2014 - 2021

Assistant Professor

Erciyes University, Tıp Fakültesi, Temel Tıp Bilimleri

2013 - 2014

2013 - 2014

Lecturer PhD

Erciyes University, Tıp Fakültesi, Temel Tıp Bilimleri

Courses

Doctorate

Doctorate

Pluripotent Özellik ve Farklılaşma

Postgraduate

Postgraduate

Kök Hücreler ve Rejeneratif Tıp

Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes

2017

2017

Long Term Exposure to Myrtucommulone-A Changes CD105 Expression and Differentiation Potential of Mesenchymal Stem Cells

Izgi K., Sonmez M. F. , CANATAN H., Iskender B.

TISSUE ENGINEERING AND REGENERATIVE MEDICINE, vol.14, no.2, pp.113-121, 2017 (Journal Indexed in SCI) Creative Commons License identifier identifier identifier

2017

2017

Current status in cancer cell reprogramming and its clinical implications

Izgi K., CANATAN H., Iskender B.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.143, no.3, pp.371-383, 2017 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

2017

2017

Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A

Izgia K., Iskender B. , Sakalar C., Arslanhan A., Yuksek E. H. , Hizar E., et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol.17, no.3, pp.404-414, 2017 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

2016

2016

Reprogramming bladder cancer cells for studying cancer initiation and progression

Iskender B. , Izgi K., CANATAN H.

TUMOR BIOLOGY, vol.37, no.10, pp.13237-13245, 2016 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

2015

2015

Myrtucommulone-A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells

Izgi K., Iskender B. , Jauch J., Sezen S., Cakir M., Charpentier M., et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, vol.29, no.9, pp.432-439, 2015 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

2011

2011

Human feeder cell line for derivation and culture of hESc/hiPSc

McKay T. R. , Camarasa M. V. , Iskender B. , Ye J., Bates N., Miller D., et al.

STEM CELL RESEARCH, vol.7, no.2, pp.154-162, 2011 (Journal Indexed in SCI) identifier identifier identifier


Citations

Total Citations (WOS): 236

h-index (WOS): 10